Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sutro Biopharma Inc buy Wedbush

Start price
€4.58
26.03.24 / 50%
Target price
€7.38
26.03.25
Performance (%)
-23.58%
Price
€3.16
25.04.24
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -23.58%. This prediction currently runs until 26.03.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Sutro Biopharma Inc -6.509% -6.509%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Wedbush for this prediction

In the thread Sutro Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -23.58%
Target price 7.375
Change
Ends at 26.03.25

Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Wedbush from $12.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for STRO provided by MarketBeat

Stopped prediction by Wedbush for Sutro Biopharma Inc

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€4.78
03.04.24
€7.38
03.04.25
-26.78%
25.04.24

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€2.08
14.11.23
€11.07
14.11.24
68.27%
25.04.24

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€2.72
23.10.23
€11.29
23.10.24
15.44%
25.04.24

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€3.86
11.08.23
€10.95
11.08.24
-18.13%
25.04.24